Stryker raises annual profit forecast on steady demand for surgical devices

Stryker (SYK.N) raised its annual profit forecast and surpassed Q2 earnings and revenue estimates, driven by robust demand for medical and surgical devices, particularly from elective procedures. The company also benefited from a reduced annual tariff impact estimate, now $175 million, contributing to its new 2025 EPS forecast of $13.40-$13.60, exceeding analyst expectations. This performance underscores continued strength in the medical device sector and effective navigation of trade dynamics.

Analysis

Stryker reported a robust second quarter, exceeding analyst expectations on both revenue and earnings with figures of $6.02 billion and $3.13 per share, respectively. This performance was primarily driven by continued strong demand for elective procedures, which fueled a significant 17.3% sales increase in its Medical Surgery and Neurotechnology division to $3.77 billion. In contrast, the Orthopedics segment posted more modest growth of 2%. Critically, the company has raised its full-year 2025 profit forecast to a range of $13.40 to $13.60 per share, lifting the midpoint above the analyst consensus of $13.35. This improved outlook is supported by a reduction in the company's estimated annual tariff impact from $200 million down to $175 million, reflecting a more favorable trade environment and proactive supply chain optimization.

Key Decisions for Investors

• The strong earnings beat and upwardly revised 2025 EPS guidance, which now surpasses analyst consensus, signals continued fundamental strength and could justify a positive re-rating of the stock.
• Investors should closely monitor the growth trajectory of the Orthopedics segment, as its modest 2% sales increase lags significantly behind the 17.3% growth in the Medical Surgery and Neurotechnology unit, making it a key area for evaluating balanced growth.
• While the reduced tariff forecast is a clear positive, investors should remain attentive to developments in international trade policy, as this remains a key variable influencing the company's cost structure and margin profile.